Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Jerash Holdings (US) (JRSH) EBITDA (2016 - 2025)

Jerash Holdings (US) filings provide 10 years of EBITDA readings, the most recent being $1.2 million for Q4 2025.

  • On a quarterly basis, EBITDA rose 935.02% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a 145.84% increase, with the full-year FY2025 number at -$860732.0, up 64.3% from a year prior.
  • EBITDA hit $1.2 million in Q4 2025 for Jerash Holdings (US), up from $444390.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $4.4 million in Q3 2021 to a low of -$3.4 million in Q1 2024.
  • Median EBITDA over the past 5 years was $423128.5 (2023), compared with a mean of $480327.0.
  • Biggest five-year swings in EBITDA: surged 1445.74% in 2021 and later tumbled 1659.53% in 2023.
  • Jerash Holdings (US)'s EBITDA stood at $1.7 million in 2021, then tumbled by 45.92% to $928622.0 in 2022, then crashed by 65.55% to $319884.0 in 2023, then plummeted by 145.88% to -$146775.0 in 2024, then surged by 935.02% to $1.2 million in 2025.
  • The last three reported values for EBITDA were $1.2 million (Q4 2025), $444390.0 (Q3 2025), and $328240.0 (Q2 2025) per Business Quant data.